Tag: Jerry St. Peter

Japan-based Santen acquires US ophthalmic company Eyevance Pharmaceuticals

pharmanewsdaily- September 17, 2020

Santen acquisition of Eyevance : Santen Pharmaceutical, a Japanese pharma company specialized in ophthalmology, has acquired US ophthalmic company Eyevance Pharmaceuticals for $225 million in ... Read More

Eyevance bags global rights of ophthalmic drug Nexagon from OcuNexus

pharmanewsdaily- October 3, 2018

Eyevance Pharmaceuticals has acquired global licensing rights of ophthalmic drug Nexagon, a 30-base antisense oligomer, from OcuNexus Therapeutics which is being developed for the treatment ... Read More